S428-0917 Screening compound: 1,4-dihydrochromeno[4,3-c]pyrazol-3-yl{3-[(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)methyl]piperidino}methanone

S428-0917 Screening compound: 1,4-dihydrochromeno[4,3-c]pyrazol-3-yl{3-[(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)methyl]piperidino}methanone
S428-0917 Screening compound: 1,4-dihydrochromeno[4,3-c]pyrazol-3-yl{3-[(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)methyl]piperidino}methanone alternative view

Chemical Structure Depiction of ChemDiv screening compound S428-0917
1,4-dihydrochromeno[4,3-c]pyrazol-3-yl{3-[(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)methyl]piperidino}methanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S428-0917

Molecular Formula

C24H27N5O4 (C24 H27 N5 O4)

Compound Name

1,4-dihydrochromeno[4,3-c]pyrazol-3-yl{3-[(3-tetrahydro-2H-pyran-4-yl-1,2,4-oxadiazol-5-yl)methyl]piperidino}methanone

IUPAC name

1-{1H4H-chromeno[43-c]pyrazole-3-carbonyl}-3-{[3-(oxan-4-yl)-124-oxadiazol-5-yl]methyl}piperidine

SMILES

O=C(c1n[nH]c-2c1COc1c2cccc1)N1CC(Cc2nc(C3CCOCC3)no2)CCC1

InChI

InChI=1S/C24H27N5O4/c30-24(22-18-14-32-19-6-2-1-5-17(19)21(18)26-27-22)29-9-3-4-15(13-29)12-20-25-23(28-33-20)16-7-10-31-11-8-16/h1-2,5-6,15-16H,3-4,7-14H2,(H,26,27)/t15-/m1/s1

InChI Key

RIHZKGVHYYZFBG-OAHLLOKOSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

449.51

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.294

Distribution Coefficient, logD

3.294

Water Solubility, LogSw

-3.77

Polar Surface Area

88.484

Acid Dissociation Constant (pKa)

6.53

Base Dissociation Constant (pKb)

-1.85

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

S428-0917 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S428-0917 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S428-0917?
Check Price and Availability of S428-0917, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S428-0917 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S428-0917
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S428-0917
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S428-0917 available by request